With long-term exposure (at least 24 weeks), approximately half of adolescent patients gained ≥ 15% and almost a third gained ≥ 25% of their baseline body weight.
Pikaajalise avaldumise puhul (vähemalt 24 nädalat) tõusis ligikaudu poolte noorukieas patsientide kehakaal ≥ 15% ja peaaegu kolmandiku kaal tõusis ≥ 25% nende esialgsest kehakaalust.